Net Loss per Share (Tables)

12 Months Ended

Dec. 31, 2023

Anti-dilutive securities excluded from the computation of earnings per share

For the years ended December 31, 2023 and 2022 the following potentially dilutive securities were excluded from the computation of diluted earnings per share because their effects would be antidilutive:


	December 31,
	2023	2022
Common stock warrants - equity	3,627,409	3,610,743
Assumed conversion of preferred stock warrants	4,149,994	—
Assumed conversion of preferred stock	4,344,909	1,135,721
Assumed conversion of convertible notes	488,031	488,031
Stock options	4,183,232	2,235,052
Total	16,793,575	7,469,547

Summary of reconciliation of weighted average shares outstanding calculation

The following tables provides a reconciliation of the weighted average shares outstanding calculation for the year-ended December 31, 2023 and 2022.


	Year ended December 31,
		2023	2022
Weighted average shares issued		15,039,630	8,290,529
Weighted average pre-funded warrants		1,190,301	574,086
Weighted average shares outstanding		16,229,931	8,864,615